{"id":314273,"date":"2025-07-19T05:01:24","date_gmt":"2025-07-19T05:01:24","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/pfizer-stock-split-history-2\/"},"modified":"2025-07-19T05:01:24","modified_gmt":"2025-07-19T05:01:24","slug":"pfizer-stock-split-history","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/","title":{"rendered":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":259834,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[16],"tags":[28,45,44],"class_list":["post-314273","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-data","tag-investment","tag-stock","tag-strategy"],"acf":{"h1":"Pfizer Hisse B\u00f6l\u00fcnme Ge\u00e7mi\u015fi","h1_source":{"label":"H1","type":"text","formatted_value":"Pfizer Hisse B\u00f6l\u00fcnme Ge\u00e7mi\u015fi"},"description":"Pfizer hisse senedi b\u00f6l\u00fcnme ge\u00e7mi\u015fi kapsaml\u0131 veri ve analizlerle a\u00e7\u0131kland\u0131. Bug\u00fcn daha ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in gizli PFE hisse senedi b\u00f6l\u00fcnme kal\u0131plar\u0131n\u0131 Pocket Option ile ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Pfizer hisse senedi b\u00f6l\u00fcnme ge\u00e7mi\u015fi kapsaml\u0131 veri ve analizlerle a\u00e7\u0131kland\u0131. Bug\u00fcn daha ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in gizli PFE hisse senedi b\u00f6l\u00fcnme kal\u0131plar\u0131n\u0131 Pocket Option ile ke\u015ffedin."},"intro":"Pfizer hisse b\u00f6l\u00fcnme ge\u00e7mi\u015fini anlamak, sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn en k\u00f6kl\u00fc oyuncular\u0131ndan biri arac\u0131l\u0131\u011f\u0131yla getirilerini maksimize etmeyi ama\u00e7layan yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok \u00f6nemlidir. Bu analiz, PFE'nin kurumsal eylemler zaman \u00e7izelgesini, b\u00f6l\u00fcnme ayarl\u0131 de\u011ferleme etkilerini ve bu tarihsel kal\u0131plar\u0131n gelecekteki yat\u0131r\u0131m stratejileri i\u00e7in ne g\u00f6sterebilece\u011fini ara\u015ft\u0131r\u0131yor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Pfizer hisse b\u00f6l\u00fcnme ge\u00e7mi\u015fini anlamak, sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn en k\u00f6kl\u00fc oyuncular\u0131ndan biri arac\u0131l\u0131\u011f\u0131yla getirilerini maksimize etmeyi ama\u00e7layan yat\u0131r\u0131mc\u0131lar i\u00e7in \u00e7ok \u00f6nemlidir. Bu analiz, PFE'nin kurumsal eylemler zaman \u00e7izelgesini, b\u00f6l\u00fcnme ayarl\u0131 de\u011ferleme etkilerini ve bu tarihsel kal\u0131plar\u0131n gelecekteki yat\u0131r\u0131m stratejileri i\u00e7in ne g\u00f6sterebilece\u011fini ara\u015ft\u0131r\u0131yor."},"body_html":"<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Kapsaml\u0131 Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: 1983-G\u00fcn\u00fcm\u00fcz<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esini takip etmek, ila\u00e7 devinin piyasa eri\u015filebilirli\u011fini korumak i\u00e7in hisse yap\u0131s\u0131n\u0131 ayarlad\u0131\u011f\u0131 be\u015f stratejik an\u0131 ortaya koyuyor. Pocket Option ara\u00e7lar\u0131n\u0131 kullanan yat\u0131r\u0131mc\u0131lar i\u00e7in bu tarihsel kal\u0131plar, PFE'nin de\u011ferleme metriklerini bug\u00fcn de etkilemeye devam eden kritik yat\u0131r\u0131m \u00f6l\u00e7\u00fctleri sunar.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Tarih<\/th><th>B\u00f6l\u00fcnme Oran\u0131<\/th><th>B\u00f6l\u00fcnme \u00d6ncesi Fiyat<\/th><th>B\u00f6l\u00fcnme Sonras\u0131 Fiyat<\/th><th>Piyasa Kataliz\u00f6r\u00fc<\/th><\/tr><\/thead><tbody><tr><td>30 Haziran 1983<\/td><td>2:1<\/td><td>$79.63<\/td><td>$39.82<\/td><td>Feldene pazar geni\u015flemesi<\/td><\/tr><tr><td>24 Ocak 1989<\/td><td>3:1<\/td><td>$76.12<\/td><td>$25.37<\/td><td>Procardia XL lansman\u0131<\/td><\/tr><tr><td>29 Nisan 1991<\/td><td>2:1<\/td><td>$69.75<\/td><td>$34.88<\/td><td>Zoloft tan\u0131t\u0131m\u0131<\/td><\/tr><tr><td>2 Haziran 1997<\/td><td>2:1<\/td><td>$97.25<\/td><td>$48.63<\/td><td>Lipitor at\u0131l\u0131m\u0131<\/td><\/tr><tr><td>30 Haziran 1999<\/td><td>3:1<\/td><td>$117.50<\/td><td>$39.17<\/td><td>Viagra pazar hakimiyeti<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pfizer'e 1983'teki ilk b\u00f6l\u00fcnmesinden \u00f6nce yap\u0131lan 10.000 dolarl\u0131k bir yat\u0131r\u0131m, bu be\u015f b\u00f6l\u00fcnmenin \u00e7arpan etkisiyle bug\u00fcn yakla\u015f\u0131k 3.600 hisseye d\u00f6n\u00fc\u015fm\u00fc\u015f olurdu (\u00e7arpan fakt\u00f6r\u00fc: 2\u00d73\u00d72\u00d72\u00d73=72). Bu, PFE hisse b\u00f6l\u00fcnme tarih\u00e7esinin, son fiyat dalgalanmalar\u0131na ra\u011fmen hisse birikimi yoluyla \u00f6nemli de\u011fer yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Pfizer Neden 1999'dan Beri Hisselerini B\u00f6lmedi?<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pfizer hisse b\u00f6l\u00fcnmelerinin 25+ y\u0131ll\u0131k yoklu\u011fu, hem kurumsal stratejide hem de piyasa dinamiklerinde temel de\u011fi\u015fiklikleri yans\u0131t\u0131yor:<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Kurumsal sahiplik 1999'da %67'den 2023'e kadar %74'e y\u00fckseldi, perakende eri\u015filebilirlik endi\u015felerini azaltt\u0131<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>K\u0131smi hisse yat\u0131r\u0131m\u0131, b\u00f6l\u00fcnmelerin ana gerek\u00e7esini ortadan kald\u0131rd\u0131<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>2000-2010 hisse fiyat\u0131 %40 d\u00fc\u015f\u00fc\u015f g\u00f6sterdi, b\u00f6l\u00fcnme gereklili\u011fini ortadan kald\u0131rd\u0131<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>18 ard\u0131\u015f\u0131k y\u0131ll\u0131k art\u0131\u015fla temett\u00fc b\u00fcy\u00fcme stratejisi ortaya \u00e7\u0131kt\u0131<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Y\u0131ll\u0131k temett\u00fc \u00f6demesi 2000'de hisse ba\u015f\u0131na $0.46'dan 2023'te $1.64'e y\u00fckseldi<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>\"Pfizer hisse b\u00f6l\u00fcnd\u00fc m\u00fc\" eylemlerinin bug\u00fcn hala ge\u00e7erli olup olmad\u0131\u011f\u0131n\u0131 analiz ederken, Pocket Option yat\u0131r\u0131mc\u0131lar\u0131 Pfizer'in odak noktas\u0131n\u0131n, birincil hissedar getiri mekanizmas\u0131 olarak temett\u00fc b\u00fcy\u00fcmesine kesin bir \u015fekilde kayd\u0131\u011f\u0131n\u0131 not etmelidir. \u015eirket, 1999'daki son b\u00f6l\u00fcnmesinden bu yana temett\u00fcler yoluyla hissedarlara 140 milyar dolardan fazla geri d\u00f6n\u00fc\u015f sa\u011flad\u0131.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>B\u00f6l\u00fcnme D\u00f6nemleri Boyunca Yat\u0131r\u0131m Performans\u0131<\/h2><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Yat\u0131r\u0131m D\u00f6nemi<\/th><th>Ba\u015flang\u0131\u00e7 $10,000<\/th><th>B\u00f6l\u00fcnme Ayarl\u0131 B\u00fcy\u00fcme<\/th><th>2025'teki De\u011fer<\/th><th>Y\u0131ll\u0131k Bile\u015fik B\u00fcy\u00fcme Oran\u0131<\/th><th>Temett\u00fc Katk\u0131s\u0131<\/th><\/tr><\/thead><tbody><tr><td>1980-1999 (B\u00f6l\u00fcnme D\u00f6nemi)<\/td><td>$10,000<\/td><td>Hisseler: 500 \u2192 18,000<\/td><td>$720,000<\/td><td>%10.1<\/td><td>Getirilerin %22'si<\/td><\/tr><tr><td>2000-2025 (B\u00f6l\u00fcnme Sonras\u0131 D\u00f6nem)<\/td><td>$10,000<\/td><td>B\u00f6l\u00fcnme yok (250 hisse)<\/td><td>$10,000<\/td><td>%0.0<\/td><td>Getirilerin %100'\u00fc<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Bu keskin performans fark\u0131, Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esinin \u015firketin hiper b\u00fcy\u00fcme a\u015famas\u0131yla \u00f6rt\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc, mevcut d\u00f6nemin ise esas olarak sermaye takdirinden ziyade gelir yoluyla de\u011fer sa\u011flad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Pfizer'in B\u00f6l\u00fcnme Stratejisini \u0130la\u00e7 Sekt\u00f6r\u00fcndeki Rakipleriyle Kar\u015f\u0131la\u015ft\u0131rma<\/h2><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>\u015eirket<\/th><th>1980'den Beri B\u00f6l\u00fcnmeler<\/th><th>En Son B\u00f6l\u00fcnme<\/th><th>Mevcut F\/K Oran\u0131<\/th><th>10 Y\u0131ll\u0131k Getiri<\/th><th>Temett\u00fc Verimi<\/th><\/tr><\/thead><tbody><tr><td>Pfizer (PFE)<\/td><td>5<\/td><td>1999<\/td><td>12.5x<\/td><td>%78<\/td><td>%4.3<\/td><\/tr><tr><td>Johnson &amp; Johnson (JNJ)<\/td><td>3<\/td><td>2001<\/td><td>15.2x<\/td><td>%112<\/td><td>%3.1<\/td><\/tr><tr><td>Eli Lilly (LLY)<\/td><td>2<\/td><td>1997<\/td><td>47.8x<\/td><td>%923<\/td><td>%0.8<\/td><\/tr><tr><td>Merck (MRK)<\/td><td>4<\/td><td>1999<\/td><td>17.3x<\/td><td>%153<\/td><td>%2.7<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Bu kar\u015f\u0131la\u015ft\u0131rma, Eli Lilly'nin y\u00fcksek hisse fiyat\u0131n\u0131 korumas\u0131na ra\u011fmen ola\u011fan\u00fcst\u00fc getiriler elde ederek, sekt\u00f6r genelinde b\u00f6l\u00fcnmelerin terk edildi\u011fini ortaya koyuyor. Pocket Option kullan\u0131c\u0131lar\u0131 i\u00e7in ila\u00e7 yat\u0131r\u0131mlar\u0131n\u0131 analiz ederken, bu durum piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131n hisse fiyat\u0131 eri\u015filebilirli\u011finden ziyade b\u00fcy\u00fcme beklentilerini de\u011ferlemeye kayd\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Pfizer Yeniden B\u00f6l\u00fcnecek mi? \u0130zlenecek Anahtar G\u00f6stergeler<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Gelecekteki Pfizer hisse b\u00f6l\u00fcnmelerini tahmin etmek belirsizlik i\u00e7erirken, b\u00f6yle bir karardan \u00f6nce genellikle belirli g\u00f6stergeler ortaya \u00e7\u0131kar:<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse fiyat\u0131n\u0131n 6+ ay boyunca s\u00fcrekli olarak $100 \u00fczerinde i\u015flem g\u00f6rmesi<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u0130leriye d\u00f6n\u00fck kazan\u00e7lar \u00fczerinde F\/K oran\u0131n\u0131n 20+ geni\u015flemesi<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>COVID a\u015f\u0131lar\u0131n\u0131n \u00f6tesinde mRNA hatt\u0131n\u0131n ba\u015far\u0131l\u0131 ticarile\u015ftirilmesi<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Perakende yat\u0131r\u0131mc\u0131 engellerini g\u00f6steren %20+ i\u015flem hacmi d\u00fc\u015f\u00fc\u015f\u00fc<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>12 ayl\u0131k bir d\u00f6nemde birden fazla ila\u00e7 sekt\u00f6r\u00fcndeki rakiplerin b\u00f6l\u00fcnme uygulamas\u0131<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option analiz ara\u00e7lar\u0131, yat\u0131r\u0131mc\u0131lara genellikle b\u00f6l\u00fcnme kararlar\u0131ndan \u00f6nce gelen bu belirli e\u015fikleri izlemekte yard\u0131mc\u0131 olabilir. Ancak, Pfizer'in mevcut $30-40 i\u015flem aral\u0131\u011f\u0131 ve gelir odakl\u0131 yat\u0131r\u0131mc\u0131 taban\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, yak\u0131n vadede bir b\u00f6l\u00fcnme olduk\u00e7a olas\u0131 g\u00f6r\u00fcnm\u00fcyor.<\/p><\/div>[cta_button text=\"\"]<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Sonu\u00e7: Pfizer'in B\u00f6l\u00fcnme Tarih\u00e7esini Bug\u00fcn\u00fcn Yat\u0131r\u0131m Stratejisinde Kullanma<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Kapsaml\u0131 Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esi, kurumsal eylemlerin \u015firketin geni\u015fleme a\u015famas\u0131nda nas\u0131l b\u00fcy\u00fcme g\u00f6stergeleri olarak hizmet etti\u011fini g\u00f6stermektedir. G\u00fcn\u00fcm\u00fcz yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Pfizer'in temett\u00fc odakl\u0131 bir modele ge\u00e7i\u015fi, de\u011ferleme yakla\u015f\u0131mlar\u0131n\u0131n ayarlanmas\u0131n\u0131 gerektirir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Gelecekteki b\u00f6l\u00fcnmeleri beklemek yerine, Pocket Option kullan\u0131c\u0131lar\u0131 Pfizer'i \u015fu temellere g\u00f6re de\u011ferlendirmelidir:<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Temett\u00fc kar\u015f\u0131lama oran\u0131 (\u015fu anda 2.7x, s\u00fcrd\u00fcr\u00fclebilirli\u011fi g\u00f6steriyor)<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Pipeline gelir potansiyeli (mevcut ileri a\u015fama adaylardan beklenen zirve sat\u0131\u015flarda $25B+)<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>COVID sonras\u0131 stratejik konumlanma ana tedavi alanlar\u0131nda<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse geri al\u0131m program\u0131 uygulamas\u0131 ($4B kalan yetki)<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>\"Pfizer hisse b\u00f6l\u00fcnd\u00fc m\u00fc\" kal\u0131plar\u0131n\u0131n yeniden ba\u015flay\u0131p ba\u015flamayaca\u011f\u0131n\u0131 anlamak, \u015firketin olgunla\u015fmas\u0131n\u0131n sermaye tahsis \u00f6nceliklerini temelden de\u011fi\u015ftirdi\u011fini kabul etmeyi gerektirir. Tarihsel b\u00f6l\u00fcnmeler, erken yat\u0131r\u0131mc\u0131lar i\u00e7in hisseleri 72 kat art\u0131r\u0131rken, bug\u00fcn\u00fcn hissedarlar\u0131 esas olarak hisse say\u0131s\u0131 ayarlamalar\u0131 yerine s\u00fcrekli artan temett\u00fcler yoluyla sermaye geri d\u00f6n\u00fc\u015f\u00fc taahh\u00fcd\u00fcnden faydalanmaktad\u0131r.<\/p><\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Kapsaml\u0131 Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: 1983-G\u00fcn\u00fcm\u00fcz<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esini takip etmek, ila\u00e7 devinin piyasa eri\u015filebilirli\u011fini korumak i\u00e7in hisse yap\u0131s\u0131n\u0131 ayarlad\u0131\u011f\u0131 be\u015f stratejik an\u0131 ortaya koyuyor. Pocket Option ara\u00e7lar\u0131n\u0131 kullanan yat\u0131r\u0131mc\u0131lar i\u00e7in bu tarihsel kal\u0131plar, PFE&#8217;nin de\u011ferleme metriklerini bug\u00fcn de etkilemeye devam eden kritik yat\u0131r\u0131m \u00f6l\u00e7\u00fctleri sunar.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>B\u00f6l\u00fcnme Oran\u0131<\/th>\n<th>B\u00f6l\u00fcnme \u00d6ncesi Fiyat<\/th>\n<th>B\u00f6l\u00fcnme Sonras\u0131 Fiyat<\/th>\n<th>Piyasa Kataliz\u00f6r\u00fc<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 Haziran 1983<\/td>\n<td>2:1<\/td>\n<td>$79.63<\/td>\n<td>$39.82<\/td>\n<td>Feldene pazar geni\u015flemesi<\/td>\n<\/tr>\n<tr>\n<td>24 Ocak 1989<\/td>\n<td>3:1<\/td>\n<td>$76.12<\/td>\n<td>$25.37<\/td>\n<td>Procardia XL lansman\u0131<\/td>\n<\/tr>\n<tr>\n<td>29 Nisan 1991<\/td>\n<td>2:1<\/td>\n<td>$69.75<\/td>\n<td>$34.88<\/td>\n<td>Zoloft tan\u0131t\u0131m\u0131<\/td>\n<\/tr>\n<tr>\n<td>2 Haziran 1997<\/td>\n<td>2:1<\/td>\n<td>$97.25<\/td>\n<td>$48.63<\/td>\n<td>Lipitor at\u0131l\u0131m\u0131<\/td>\n<\/tr>\n<tr>\n<td>30 Haziran 1999<\/td>\n<td>3:1<\/td>\n<td>$117.50<\/td>\n<td>$39.17<\/td>\n<td>Viagra pazar hakimiyeti<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pfizer&#8217;e 1983&#8217;teki ilk b\u00f6l\u00fcnmesinden \u00f6nce yap\u0131lan 10.000 dolarl\u0131k bir yat\u0131r\u0131m, bu be\u015f b\u00f6l\u00fcnmenin \u00e7arpan etkisiyle bug\u00fcn yakla\u015f\u0131k 3.600 hisseye d\u00f6n\u00fc\u015fm\u00fc\u015f olurdu (\u00e7arpan fakt\u00f6r\u00fc: 2\u00d73\u00d72\u00d72\u00d73=72). Bu, PFE hisse b\u00f6l\u00fcnme tarih\u00e7esinin, son fiyat dalgalanmalar\u0131na ra\u011fmen hisse birikimi yoluyla \u00f6nemli de\u011fer yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Pfizer Neden 1999&#8217;dan Beri Hisselerini B\u00f6lmedi?<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pfizer hisse b\u00f6l\u00fcnmelerinin 25+ y\u0131ll\u0131k yoklu\u011fu, hem kurumsal stratejide hem de piyasa dinamiklerinde temel de\u011fi\u015fiklikleri yans\u0131t\u0131yor:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Kurumsal sahiplik 1999&#8217;da %67&#8217;den 2023&#8217;e kadar %74&#8217;e y\u00fckseldi, perakende eri\u015filebilirlik endi\u015felerini azaltt\u0131<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>K\u0131smi hisse yat\u0131r\u0131m\u0131, b\u00f6l\u00fcnmelerin ana gerek\u00e7esini ortadan kald\u0131rd\u0131<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>2000-2010 hisse fiyat\u0131 %40 d\u00fc\u015f\u00fc\u015f g\u00f6sterdi, b\u00f6l\u00fcnme gereklili\u011fini ortadan kald\u0131rd\u0131<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>18 ard\u0131\u015f\u0131k y\u0131ll\u0131k art\u0131\u015fla temett\u00fc b\u00fcy\u00fcme stratejisi ortaya \u00e7\u0131kt\u0131<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Y\u0131ll\u0131k temett\u00fc \u00f6demesi 2000&#8217;de hisse ba\u015f\u0131na $0.46&#8217;dan 2023&#8217;te $1.64&#8217;e y\u00fckseldi<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>&#8220;Pfizer hisse b\u00f6l\u00fcnd\u00fc m\u00fc&#8221; eylemlerinin bug\u00fcn hala ge\u00e7erli olup olmad\u0131\u011f\u0131n\u0131 analiz ederken, Pocket Option yat\u0131r\u0131mc\u0131lar\u0131 Pfizer&#8217;in odak noktas\u0131n\u0131n, birincil hissedar getiri mekanizmas\u0131 olarak temett\u00fc b\u00fcy\u00fcmesine kesin bir \u015fekilde kayd\u0131\u011f\u0131n\u0131 not etmelidir. \u015eirket, 1999&#8217;daki son b\u00f6l\u00fcnmesinden bu yana temett\u00fcler yoluyla hissedarlara 140 milyar dolardan fazla geri d\u00f6n\u00fc\u015f sa\u011flad\u0131.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>B\u00f6l\u00fcnme D\u00f6nemleri Boyunca Yat\u0131r\u0131m Performans\u0131<\/h2>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Yat\u0131r\u0131m D\u00f6nemi<\/th>\n<th>Ba\u015flang\u0131\u00e7 $10,000<\/th>\n<th>B\u00f6l\u00fcnme Ayarl\u0131 B\u00fcy\u00fcme<\/th>\n<th>2025&#8217;teki De\u011fer<\/th>\n<th>Y\u0131ll\u0131k Bile\u015fik B\u00fcy\u00fcme Oran\u0131<\/th>\n<th>Temett\u00fc Katk\u0131s\u0131<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1980-1999 (B\u00f6l\u00fcnme D\u00f6nemi)<\/td>\n<td>$10,000<\/td>\n<td>Hisseler: 500 \u2192 18,000<\/td>\n<td>$720,000<\/td>\n<td>%10.1<\/td>\n<td>Getirilerin %22&#8217;si<\/td>\n<\/tr>\n<tr>\n<td>2000-2025 (B\u00f6l\u00fcnme Sonras\u0131 D\u00f6nem)<\/td>\n<td>$10,000<\/td>\n<td>B\u00f6l\u00fcnme yok (250 hisse)<\/td>\n<td>$10,000<\/td>\n<td>%0.0<\/td>\n<td>Getirilerin %100&#8217;\u00fc<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Bu keskin performans fark\u0131, Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esinin \u015firketin hiper b\u00fcy\u00fcme a\u015famas\u0131yla \u00f6rt\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc, mevcut d\u00f6nemin ise esas olarak sermaye takdirinden ziyade gelir yoluyla de\u011fer sa\u011flad\u0131\u011f\u0131n\u0131 g\u00f6stermektedir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Pfizer&#8217;in B\u00f6l\u00fcnme Stratejisini \u0130la\u00e7 Sekt\u00f6r\u00fcndeki Rakipleriyle Kar\u015f\u0131la\u015ft\u0131rma<\/h2>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>\u015eirket<\/th>\n<th>1980&#8217;den Beri B\u00f6l\u00fcnmeler<\/th>\n<th>En Son B\u00f6l\u00fcnme<\/th>\n<th>Mevcut F\/K Oran\u0131<\/th>\n<th>10 Y\u0131ll\u0131k Getiri<\/th>\n<th>Temett\u00fc Verimi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Pfizer (PFE)<\/td>\n<td>5<\/td>\n<td>1999<\/td>\n<td>12.5x<\/td>\n<td>%78<\/td>\n<td>%4.3<\/td>\n<\/tr>\n<tr>\n<td>Johnson &amp; Johnson (JNJ)<\/td>\n<td>3<\/td>\n<td>2001<\/td>\n<td>15.2x<\/td>\n<td>%112<\/td>\n<td>%3.1<\/td>\n<\/tr>\n<tr>\n<td>Eli Lilly (LLY)<\/td>\n<td>2<\/td>\n<td>1997<\/td>\n<td>47.8x<\/td>\n<td>%923<\/td>\n<td>%0.8<\/td>\n<\/tr>\n<tr>\n<td>Merck (MRK)<\/td>\n<td>4<\/td>\n<td>1999<\/td>\n<td>17.3x<\/td>\n<td>%153<\/td>\n<td>%2.7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Bu kar\u015f\u0131la\u015ft\u0131rma, Eli Lilly&#8217;nin y\u00fcksek hisse fiyat\u0131n\u0131 korumas\u0131na ra\u011fmen ola\u011fan\u00fcst\u00fc getiriler elde ederek, sekt\u00f6r genelinde b\u00f6l\u00fcnmelerin terk edildi\u011fini ortaya koyuyor. Pocket Option kullan\u0131c\u0131lar\u0131 i\u00e7in ila\u00e7 yat\u0131r\u0131mlar\u0131n\u0131 analiz ederken, bu durum piyasa duyarl\u0131l\u0131\u011f\u0131n\u0131n hisse fiyat\u0131 eri\u015filebilirli\u011finden ziyade b\u00fcy\u00fcme beklentilerini de\u011ferlemeye kayd\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Pfizer Yeniden B\u00f6l\u00fcnecek mi? \u0130zlenecek Anahtar G\u00f6stergeler<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Gelecekteki Pfizer hisse b\u00f6l\u00fcnmelerini tahmin etmek belirsizlik i\u00e7erirken, b\u00f6yle bir karardan \u00f6nce genellikle belirli g\u00f6stergeler ortaya \u00e7\u0131kar:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse fiyat\u0131n\u0131n 6+ ay boyunca s\u00fcrekli olarak $100 \u00fczerinde i\u015flem g\u00f6rmesi<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u0130leriye d\u00f6n\u00fck kazan\u00e7lar \u00fczerinde F\/K oran\u0131n\u0131n 20+ geni\u015flemesi<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>COVID a\u015f\u0131lar\u0131n\u0131n \u00f6tesinde mRNA hatt\u0131n\u0131n ba\u015far\u0131l\u0131 ticarile\u015ftirilmesi<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Perakende yat\u0131r\u0131mc\u0131 engellerini g\u00f6steren %20+ i\u015flem hacmi d\u00fc\u015f\u00fc\u015f\u00fc<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>12 ayl\u0131k bir d\u00f6nemde birden fazla ila\u00e7 sekt\u00f6r\u00fcndeki rakiplerin b\u00f6l\u00fcnme uygulamas\u0131<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option analiz ara\u00e7lar\u0131, yat\u0131r\u0131mc\u0131lara genellikle b\u00f6l\u00fcnme kararlar\u0131ndan \u00f6nce gelen bu belirli e\u015fikleri izlemekte yard\u0131mc\u0131 olabilir. Ancak, Pfizer&#8217;in mevcut $30-40 i\u015flem aral\u0131\u011f\u0131 ve gelir odakl\u0131 yat\u0131r\u0131mc\u0131 taban\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, yak\u0131n vadede bir b\u00f6l\u00fcnme olduk\u00e7a olas\u0131 g\u00f6r\u00fcnm\u00fcyor.<\/p>\n<\/div>\n    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\"><\/span>\n        <\/a>\n    <\/div>\n    \n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Sonu\u00e7: Pfizer&#8217;in B\u00f6l\u00fcnme Tarih\u00e7esini Bug\u00fcn\u00fcn Yat\u0131r\u0131m Stratejisinde Kullanma<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Kapsaml\u0131 Pfizer hisse b\u00f6l\u00fcnme tarih\u00e7esi, kurumsal eylemlerin \u015firketin geni\u015fleme a\u015famas\u0131nda nas\u0131l b\u00fcy\u00fcme g\u00f6stergeleri olarak hizmet etti\u011fini g\u00f6stermektedir. G\u00fcn\u00fcm\u00fcz yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Pfizer&#8217;in temett\u00fc odakl\u0131 bir modele ge\u00e7i\u015fi, de\u011ferleme yakla\u015f\u0131mlar\u0131n\u0131n ayarlanmas\u0131n\u0131 gerektirir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Gelecekteki b\u00f6l\u00fcnmeleri beklemek yerine, Pocket Option kullan\u0131c\u0131lar\u0131 Pfizer&#8217;i \u015fu temellere g\u00f6re de\u011ferlendirmelidir:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Temett\u00fc kar\u015f\u0131lama oran\u0131 (\u015fu anda 2.7x, s\u00fcrd\u00fcr\u00fclebilirli\u011fi g\u00f6steriyor)<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Pipeline gelir potansiyeli (mevcut ileri a\u015fama adaylardan beklenen zirve sat\u0131\u015flarda $25B+)<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>COVID sonras\u0131 stratejik konumlanma ana tedavi alanlar\u0131nda<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse geri al\u0131m program\u0131 uygulamas\u0131 ($4B kalan yetki)<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>&#8220;Pfizer hisse b\u00f6l\u00fcnd\u00fc m\u00fc&#8221; kal\u0131plar\u0131n\u0131n yeniden ba\u015flay\u0131p ba\u015flamayaca\u011f\u0131n\u0131 anlamak, \u015firketin olgunla\u015fmas\u0131n\u0131n sermaye tahsis \u00f6nceliklerini temelden de\u011fi\u015ftirdi\u011fini kabul etmeyi gerektirir. Tarihsel b\u00f6l\u00fcnmeler, erken yat\u0131r\u0131mc\u0131lar i\u00e7in hisseleri 72 kat art\u0131r\u0131rken, bug\u00fcn\u00fcn hissedarlar\u0131 esas olarak hisse say\u0131s\u0131 ayarlamalar\u0131 yerine s\u00fcrekli artan temett\u00fcler yoluyla sermaye geri d\u00f6n\u00fc\u015f\u00fc taahh\u00fcd\u00fcnden faydalanmaktad\u0131r.<\/p>\n<\/div>\n"},"faq":[{"question":"Pfizer'in son hisse b\u00f6l\u00fcnmesi ne zaman ger\u00e7ekle\u015fti?","answer":"Pfizer'in en son hisse b\u00f6l\u00fcnmesi, \u015firketin 3'e 1 b\u00f6l\u00fcnme uygulad\u0131\u011f\u0131 30 Haziran 1999 tarihinde ger\u00e7ekle\u015fti. O tarihten bu yana, Pfizer son 25+ y\u0131lda ba\u015fka bir hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirmedi, bunun yerine temett\u00fc b\u00fcy\u00fcmesi ve stratejik sat\u0131n almalar gibi di\u011fer hissedar de\u011feri mekanizmalar\u0131na odakland\u0131."},{"question":"Pfizer hissesi tarih boyunca ka\u00e7 kez b\u00f6l\u00fcnd\u00fc?","answer":"Pfizer, ticaret ge\u00e7mi\u015fi boyunca be\u015f hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirmi\u015ftir. Bu b\u00f6l\u00fcnmeler \u015fu tarihlerde ger\u00e7ekle\u015fmi\u015ftir: 30 Haziran 1983 (2'ye 1), 24 Ocak 1989 (3'e 1), 29 Nisan 1991 (2'ye 1), 2 Haziran 1997 (2'ye 1) ve 30 Haziran 1999 (3'e 1)."},{"question":"Pfizer'in herhangi bir b\u00f6l\u00fcnme \u00f6ncesinde sat\u0131n al\u0131nan 100 hissesinin bug\u00fcnk\u00fc de\u011feri nas\u0131l olurdu?","answer":"Bir yat\u0131r\u0131mc\u0131, 1983'teki ilk kaydedilen b\u00f6l\u00fcnmeden \u00f6nce Pfizer'den 100 hisse sat\u0131n alm\u0131\u015f olsayd\u0131, bu hisseler sonraki hisse b\u00f6l\u00fcnmeleriyle 3.600 hisseye \u00e7o\u011fal\u0131rd\u0131 (2\u00d73\u00d72\u00d72\u00d73 = 72 \u00e7arpan fakt\u00f6r\u00fc). Kesin de\u011fer, Pfizer'in mevcut hisse fiyat\u0131na ba\u011fl\u0131 olacakt\u0131r, ancak hisse ba\u015f\u0131na yakla\u015f\u0131k 40 $'da, bu pozisyon yakla\u015f\u0131k 144.000 $ de\u011ferinde olurdu."},{"question":"Pfizer neden art\u0131k hisse senetlerini b\u00f6lm\u00fcyor?","answer":"Pfizer, muhtemelen hisse senedi b\u00f6l\u00fcnmelerini birka\u00e7 fakt\u00f6rden dolay\u0131 durdurdu: kurumsal yat\u0131r\u0131mc\u0131lar aras\u0131nda daha y\u00fcksek fiyatl\u0131 hisse senetlerine y\u00f6nelik de\u011fi\u015fen piyasa tercihleri, eri\u015filebilirlik engellerini ortadan kald\u0131ran kesirli hisse senedi yat\u0131r\u0131mlar\u0131n\u0131n y\u00fckseli\u015fi, bir de\u011fer mekanizmas\u0131 olarak temett\u00fc b\u00fcy\u00fcmesinin \u00f6nceliklendirilmesi ve hisse senedi fiyat performans\u0131n\u0131n eri\u015filebilirli\u011fi s\u00fcrd\u00fcrmek i\u00e7in b\u00f6l\u00fcnmeleri gerektirmedi\u011fi d\u00f6nemler."},{"question":"Pfizer gelecekte bir hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirebilir mi?","answer":"Mevcut fiyat seviyeleri ve \u015firket stratejisi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, yak\u0131n vadede bir Pfizer hisse b\u00f6l\u00fcnmesi olas\u0131 g\u00f6r\u00fcnmemektedir. Yeniden de\u011ferlendirmeyi tetikleyebilecek fakt\u00f6rler \u015funlard\u0131r: hisse fiyat\u0131n\u0131n 100 dolar\u0131n \u00fczerinde s\u00fcrekli art\u0131\u015f\u0131, y\u00f6netimin perakende yat\u0131r\u0131mc\u0131 eri\u015fimini art\u0131rmaya y\u00f6nelik bir de\u011fi\u015fim g\u00f6stermesi, h\u0131zland\u0131r\u0131lm\u0131\u015f b\u00fcy\u00fcmeyi tetikleyen \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 \u00fcr\u00fcn ba\u015far\u0131s\u0131 veya ila\u00e7 sekt\u00f6r\u00fcndeki rakipler aras\u0131nda b\u00f6l\u00fcnme e\u011filimi."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Pfizer'in son hisse b\u00f6l\u00fcnmesi ne zaman ger\u00e7ekle\u015fti?","answer":"Pfizer'in en son hisse b\u00f6l\u00fcnmesi, \u015firketin 3'e 1 b\u00f6l\u00fcnme uygulad\u0131\u011f\u0131 30 Haziran 1999 tarihinde ger\u00e7ekle\u015fti. O tarihten bu yana, Pfizer son 25+ y\u0131lda ba\u015fka bir hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirmedi, bunun yerine temett\u00fc b\u00fcy\u00fcmesi ve stratejik sat\u0131n almalar gibi di\u011fer hissedar de\u011feri mekanizmalar\u0131na odakland\u0131."},{"question":"Pfizer hissesi tarih boyunca ka\u00e7 kez b\u00f6l\u00fcnd\u00fc?","answer":"Pfizer, ticaret ge\u00e7mi\u015fi boyunca be\u015f hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirmi\u015ftir. Bu b\u00f6l\u00fcnmeler \u015fu tarihlerde ger\u00e7ekle\u015fmi\u015ftir: 30 Haziran 1983 (2'ye 1), 24 Ocak 1989 (3'e 1), 29 Nisan 1991 (2'ye 1), 2 Haziran 1997 (2'ye 1) ve 30 Haziran 1999 (3'e 1)."},{"question":"Pfizer'in herhangi bir b\u00f6l\u00fcnme \u00f6ncesinde sat\u0131n al\u0131nan 100 hissesinin bug\u00fcnk\u00fc de\u011feri nas\u0131l olurdu?","answer":"Bir yat\u0131r\u0131mc\u0131, 1983'teki ilk kaydedilen b\u00f6l\u00fcnmeden \u00f6nce Pfizer'den 100 hisse sat\u0131n alm\u0131\u015f olsayd\u0131, bu hisseler sonraki hisse b\u00f6l\u00fcnmeleriyle 3.600 hisseye \u00e7o\u011fal\u0131rd\u0131 (2\u00d73\u00d72\u00d72\u00d73 = 72 \u00e7arpan fakt\u00f6r\u00fc). Kesin de\u011fer, Pfizer'in mevcut hisse fiyat\u0131na ba\u011fl\u0131 olacakt\u0131r, ancak hisse ba\u015f\u0131na yakla\u015f\u0131k 40 $'da, bu pozisyon yakla\u015f\u0131k 144.000 $ de\u011ferinde olurdu."},{"question":"Pfizer neden art\u0131k hisse senetlerini b\u00f6lm\u00fcyor?","answer":"Pfizer, muhtemelen hisse senedi b\u00f6l\u00fcnmelerini birka\u00e7 fakt\u00f6rden dolay\u0131 durdurdu: kurumsal yat\u0131r\u0131mc\u0131lar aras\u0131nda daha y\u00fcksek fiyatl\u0131 hisse senetlerine y\u00f6nelik de\u011fi\u015fen piyasa tercihleri, eri\u015filebilirlik engellerini ortadan kald\u0131ran kesirli hisse senedi yat\u0131r\u0131mlar\u0131n\u0131n y\u00fckseli\u015fi, bir de\u011fer mekanizmas\u0131 olarak temett\u00fc b\u00fcy\u00fcmesinin \u00f6nceliklendirilmesi ve hisse senedi fiyat performans\u0131n\u0131n eri\u015filebilirli\u011fi s\u00fcrd\u00fcrmek i\u00e7in b\u00f6l\u00fcnmeleri gerektirmedi\u011fi d\u00f6nemler."},{"question":"Pfizer gelecekte bir hisse b\u00f6l\u00fcnmesi ger\u00e7ekle\u015ftirebilir mi?","answer":"Mevcut fiyat seviyeleri ve \u015firket stratejisi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, yak\u0131n vadede bir Pfizer hisse b\u00f6l\u00fcnmesi olas\u0131 g\u00f6r\u00fcnmemektedir. Yeniden de\u011ferlendirmeyi tetikleyebilecek fakt\u00f6rler \u015funlard\u0131r: hisse fiyat\u0131n\u0131n 100 dolar\u0131n \u00fczerinde s\u00fcrekli art\u0131\u015f\u0131, y\u00f6netimin perakende yat\u0131r\u0131mc\u0131 eri\u015fimini art\u0131rmaya y\u00f6nelik bir de\u011fi\u015fim g\u00f6stermesi, h\u0131zland\u0131r\u0131lm\u0131\u015f b\u00fcy\u00fcmeyi tetikleyen \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 \u00fcr\u00fcn ba\u015far\u0131s\u0131 veya ila\u00e7 sekt\u00f6r\u00fcndeki rakipler aras\u0131nda b\u00f6l\u00fcnme e\u011filimi."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-19T05:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Tatiana OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatiana OK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\"},\"author\":{\"name\":\"Tatiana OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"headline\":\"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi\",\"datePublished\":\"2025-07-19T05:01:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\"},\"wordCount\":10,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp\",\"keywords\":[\"investment\",\"stock\",\"strategy\"],\"articleSection\":[\"Data\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\",\"name\":\"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp\",\"datePublished\":\"2025-07-19T05:01:24+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\",\"name\":\"Tatiana OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"caption\":\"Tatiana OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/tatiana\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/","og_locale":"tr_TR","og_type":"article","og_title":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-19T05:01:24+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp","type":"image\/webp"}],"author":"Tatiana OK","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Tatiana OK"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/"},"author":{"name":"Tatiana OK","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"headline":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi","datePublished":"2025-07-19T05:01:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/"},"wordCount":10,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp","keywords":["investment","stock","strategy"],"articleSection":["Data"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/","name":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp","datePublished":"2025-07-19T05:01:24+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742024349778-10891479-6.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/data\/pfizer-stock-split-history\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Hisse B\u00f6l\u00fcnme Tarih\u00e7esi: Tam Zaman \u00c7izelgesi"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d","name":"Tatiana OK","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","caption":"Tatiana OK"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/tatiana\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":314275,"slug":"pfizer-stock-split-history","post_title":"L\u1ecbch S\u1eed Chia T\u00e1ch C\u1ed5 Phi\u1ebfu Pfizer: D\u00f2ng Th\u1eddi Gian Ho\u00e0n Ch\u1ec9nh","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/data\/pfizer-stock-split-history\/"},"pt_AA":{"locale":"pt_AA","id":314270,"slug":"pfizer-stock-split-history","post_title":"Hist\u00f3rico de Desdobramento de A\u00e7\u00f5es da Pfizer: Cronograma Completo","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/data\/pfizer-stock-split-history\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/314273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=314273"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/314273\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/259834"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=314273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=314273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=314273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}